| Reduced Risk Status: |
|
| IPM Compatibility: |
Per Requester: Very Good Fit; Selective with beneficial insects and predators:06/25;
|
| Reasons for need: |
Thrips. No current products effective enough:06/25;
|
| Requesting State(s): |
CO:Tonnessen, B* ;
|
| PCR Use Pattern: |
Make 2-3 applications of Spidoxamat 17.4 WG at 19 oz per A, with 7 day RTI and 0-7 day PHI
|
| EPA Default Residue Trials: |
BULB: 1 5 6 8 10-2 11 12
|
| IR-4 Residue Trial Plan: |
|
| Residue Protocol Use Pattern: |
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
See PR 09983 for the spirotetramat version;
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|